3Andrieu-Soler C,Aubert-Pouessel A,Doat M, et al. Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rdl/rdl mouse[J]. Mol Vis, 2005,11 : 1002- 1011.
4Carrillo C, Wigdorovitz A, Trono K, et al. Induction of a virus specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants [J]. Viral Immunol,2001,14(1) :49-57.
5Goraltchouk A, Scanga V, Morshead C M, et al. Incorporation of protein eluting microspheres into biodegradable nerve guidance channels for controlled release[J].J Control Release, 2006,110 (2) :400-407.
6Joachim F. Biological safety concepts of genetically modified live bacterial vaccines[J]. Vaccine, 2006,5 : 1 - 8.
7Moorthy V S,Imoukhuede E B,Keating S,et al. Phase 1 evalua tion of 3 highly immunogenic prime-boost regimens,including a 12-month reboosting vaccination, for malaria vaccination ingambian men[J]. J Infect Dis, 2004,189 : 2213 -2219.
8Mungube E O, Tenhagen B A, Regassa F, et al. Reduced milk production in udder quarters with subclinical mastitis and associ- ated economic losses in crossbred dairy cows in ethiopia[J]. Tropical Animal Health and Production,2005,37(6):503-512.
9SouzaAP D,Haut L,Reyes-Sandoval A,et al. Recombinant vi- ruses as vaccines against viral diseases recombinant viruses as vaccines[J].Brazilian Journal of Medical and Biological Research, 2005,38:509-522.
10Susanne R,Kay E, Sven P, et al. Bovine β-defensins: identification and characterization of novel bovine β-defensin genes and their expression in mammarygland tissue[J]. Mammalian Genome,2004,15(10) :834-842.
